Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Nov 1;26(4):683–690. doi: 10.1016/j.bbmt.2019.10.029

Figure 1.

Figure 1.

(a) Cumulative incidence curves for grade III-IV acute GVHD (aGVHD) with disease relapse or death as competing risks by group (R-BEAM vs. Reduced intensity).

(b) Cumulative incidence curves for extensive chronic GVHD (cGVHD) with disease relapse or death as competing risks by group.